Zobrazeno 1 - 10
of 89
pro vyhledávání: '"J Van der Mooren"'
Publikováno v:
The Journal of Sexual Medicine. 20
Introduction Low sexual desire is the most common sexual complaint in women. As a result, many women suffer from sexual dissatisfaction and related distress which often negatively interferes with their quality of life. Currently, limited drug treatme
Publikováno v:
Gynecological Endocrinology, 28, 46-49. Taylor and Francis Ltd.
Kenemans, P & van der Mooren, M J 2012, ' Androgens and breast cancer risk ', Gynecological Endocrinology, vol. 28, pp. 46-49 . https://doi.org/10.3109/09513590.2012.651925
Kenemans, P & van der Mooren, M J 2012, ' Androgens and breast cancer risk ', Gynecological Endocrinology, vol. 28, pp. 46-49 . https://doi.org/10.3109/09513590.2012.651925
Transdermal testosterone supplementation is a treatment option for postmenopausal women with distressful decreased libido. Side effects are minor, but there is a long-term safety concern with respect to breast cancer, as women with high testosterone
Autor:
Alyde T. de Kraker, Marius J. van der Mooren, R.G.V. Smolders, Peter Kenemans, Maurice V.A.M. Kroeks
Publikováno v:
de Kraker, A T, Kenemans, P, Smolders, R G V, Kroeks, M V A M & van der Mooren, M J 2009, ' Short-term effects of two continuous combined oestrogen-progestogen therapies on several cardiovascular risk markers in healthy postmenopausal women: A randomised controlled trial ', European Journal of Obstetrics and Gynecology and Reproductive Biology, vol. 142, no. 2, pp. 139-144 . https://doi.org/10.1016/j.ejogrb.2008.10.007
European Journal of Obstetrics and Gynecology and Reproductive Biology, 142(2), 139-144. Elsevier Ireland Ltd
European Journal of Obstetrics and Gynecology and Reproductive Biology, 142(2), 139-144. Elsevier Ireland Ltd
Objective To compare the short-term effects of two oral continuous combined oestrogen–progestogen treatment regimens on blood concentrations of several cardiovascular risk markers in healthy postmenopausal women. Study design In a 12-week randomise
Autor:
Peter Kenemans, Curt W. Burger, Marius J. van der Mooren, H.R. Franke, Monique M.A. Brood-van Zanten
Publikováno v:
European Journal of Obstetrics, Gynecology and Reproductive Biology, 134(2), 143-146. Elsevier Ireland Ltd
Franke, H R, Brood-van Zanten, M M A, Burger, C W, van der Mooren, M J & Kenemans, P 2007, ' Breast cancer and climacteric complaints : Weighing up risks of hormone therapy against quality of life ', European Journal of Obstetrics and Gynecology and Reproductive Biology, vol. 134, no. 2, pp. 143-146 . https://doi.org/10.1016/j.ejogrb.2007.05.002
Franke, H R, Brood-van Zanten, M M A, Burger, C W, van der Mooren, M J & Kenemans, P 2007, ' Breast cancer and climacteric complaints : Weighing up risks of hormone therapy against quality of life ', European Journal of Obstetrics and Gynecology and Reproductive Biology, vol. 134, no. 2, pp. 143-146 . https://doi.org/10.1016/j.ejogrb.2007.05.002
Women with severe menopausal symptoms can, at their request, be treated effectively with hormone therapy. Good information about the advantages and disadvantages of hormone therapy should precede this decision. For women with breast cancer or an inhe
Autor:
Peter Kenemans, Tom Teerlink, Sonja D. Zuijdgeest-van Leeuwen, Marius J. van der Mooren, Marieke O. Verhoeven
Publikováno v:
Fertility and Sterility. 87:849-857
Objective To investigate the effects of a supplement containing soy isoflavones and Actaea racemosa L. on several coronary heart disease (CHD) risk markers in menopausal women. Design Randomized, placebo-controlled, double-blind study. Setting Nine h
Autor:
Majoie Hemelaar, Didi D.M. Braat, M. Christella L. G. D. Thomassen, Marius J. van der Mooren, Jan Rosing, Peter Kenemans
Publikováno v:
Arteriosclerosis, Thrombosis, and Vascular Biology, 26, 7, pp. 1660-6
Arteriosclerosis, Thrombosis, and Vascular Biology, 26, 1660-6
Arteriosclerosis, Thrombosis, and Vascular Biology, 26, 1660-6
Objective— To compare the effects of intranasal and oral administration of 17β-estradiol (E 2 ) and norethisterone(acetate) [NET(A)] in healthy postmenopausal women on activated protein C (APC) resistance and other hemostatic parameters associated
Publikováno v:
Gynecological Endocrinology. 22:692-697
To assess the effects of adding combined estradiol/norethisterone acetate therapy (CENT) to goserelin acetate treatment (GA) of dysfunctional uterine bleeding (DUB) in perimenopausal women.In a randomized, placebo-controlled, double-blind trial follo
Autor:
Pieter Sipkema, Raimond G. V Smolders, Iolente J M Korstjens, Helenius J. Kloosterboer, Marius J. van der Mooren, Peter Kenemans
Publikováno v:
Menopause. 12:340-347
OBJECTIVE Tibolone is a synthetic steroid used for the treatment of the symptoms of menopause that, once metabolized, has estrogenic, progestogenic, and androgenic properties. We investigated the direct vasodilatory effects of the major active tibolo
Autor:
Tatjana E. Vogelvang, Marius J. van der Mooren, Peter Kenemans, Jef J. Emeis, Johannes A. Heijst, Velja Mijatovic
Publikováno v:
American Journal of Obstetrics and Gynecology, 4, 193, 1384-1394
Vogelvang, T E, Mijatovic, V, Kenemans, P, Emeis, J J, Heijst, J A & van der Mooren, M J 2005, ' The effects of 12 weeks of HMR 3339, a novel selective estrogen receptor modulator, on markers of coagulation and fibrinolysis: a randomized, placebo-controlled, double-blind, dose-ranging study in healthy postmenopausal women ', American Journal of Obstetrics and Gynecology, vol. 193, no. 4, pp. 1384-1394 . https://doi.org/10.1016/j.ajog.2005.02.083
American Journal of Obstetrics and Gynecology, 193(4), 1384-1394. Mosby Inc.
Vogelvang, T E, Mijatovic, V, Kenemans, P, Emeis, J J, Heijst, J A & van der Mooren, M J 2005, ' The effects of 12 weeks of HMR 3339, a novel selective estrogen receptor modulator, on markers of coagulation and fibrinolysis: a randomized, placebo-controlled, double-blind, dose-ranging study in healthy postmenopausal women ', American Journal of Obstetrics and Gynecology, vol. 193, no. 4, pp. 1384-1394 . https://doi.org/10.1016/j.ajog.2005.02.083
American Journal of Obstetrics and Gynecology, 193(4), 1384-1394. Mosby Inc.
Objective: To investigate the short-term effects of HMR 3339, a novel selective estrogen receptor modulator, on markers of coagulation and fibrinolysis. Study design: In a multicenter, 14-week, randomized, placebo-controlled, double-blind, dose-rangi
Autor:
Majoie Hemelaar, W. Marchien van Baal, Marius J. van der Mooren, Casper G. Schalkwijk, Peter Kenemans, Coen D.A. Stehouwer
Publikováno v:
Menopause-The Journal of the North American Menopause Society, 12, 526-535. LIPPINCOTT WILLIAMS & WILKINS
Objective: To compare the effect of transdermal and oral estrogen therapy, the latter with or without the addition of gestodene, on plasma concentrations of markers of endothelial function and on ultrasonographic parameters of vascular function in he